Glucosamine Sulphate and Increased Level of Blood Cholesterol

This study has been completed.
Sponsor:
Collaborator:
Pharma Nord
Information provided by:
Slidgigtinstituttet
ClinicalTrials.gov Identifier:
NCT00251069
First received: November 7, 2005
Last updated: NA
Last verified: July 2005
History: No changes posted
  Purpose

Glucosamine sulphate causes no changes in blood levels of cholesterol


Condition Intervention Phase
Osteoarthritis
Drug: Glucosamine sulphate
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: Glucosamine Sulphate and Hypercholesterolaemia

Resource links provided by NLM:


Further study details as provided by Slidgigtinstituttet:

Primary Outcome Measures:
  • Levels of blood cholesterol

Secondary Outcome Measures:
  • Effect of treatment on pain

Estimated Enrollment: 66
Study Start Date: April 2005
Estimated Study Completion Date: August 2005
Detailed Description:

The effects on glucosamine sulphate on blood levels of choleterol is measuered in patients with mild to moderate osteoarthritis

  Eligibility

Ages Eligible for Study:   40 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria: Osteoarthritic pain, normal blood cholesterol levels -

Exclusion Criteria: Systemic diseases, pregnancy, need of medication besides painkillers

-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00251069

Locations
Denmark
Slidgigtinstituttet
Ishøj, Denmark, DK-2635
Sponsors and Collaborators
Slidgigtinstituttet
Pharma Nord
Investigators
Principal Investigator: Keld Ostergaard, M.D., Ph.D. Slidgigtinstituttet
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00251069     History of Changes
Other Study ID Numbers: EudraCTnr 2005-000541-11
Study First Received: November 7, 2005
Last Updated: November 7, 2005
Health Authority: Denmark: Lægemiddelstyrelsen (Danish Health Authorities)

Keywords provided by Slidgigtinstituttet:
glucosamine sulphate, osteoarthritis, cholesterol,

Additional relevant MeSH terms:
Hypercholesterolemia
Osteoarthritis
Hyperlipidemias
Dyslipidemias
Lipid Metabolism Disorders
Metabolic Diseases
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases

ClinicalTrials.gov processed this record on April 17, 2014